,trastuzumab deruxtecan
Daiichi Sankyo,AstraZeneca
['tnbc', 'mbc']
#asco22 shanu modi presents remarkable data from db04 in largely hr+ mbc in earlier line rx. 58 pts with tnbc altho similar results. 3 deaths from ild. a new standard of care. standing ovation at asco plenary! 